Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis

被引:31
|
作者
Garay, Laura [1 ,2 ]
Gonzalez Deniselle, Maria Claudia [1 ,3 ]
Sitruk-Ware, Regine [4 ]
Guennoun, Rachida [5 ]
Schumacher, Michael [5 ]
De Nicola, Alejandro F. [1 ,2 ]
机构
[1] Inst Biol & Med Expt, Lab Neuroendocrine Biochem, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Med, Dept Human Biochem, RA-1053 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Med, Dept Physiol, RA-1053 Buenos Aires, DF, Argentina
[4] Rockefeller Univ, Populat Council, New York, NY 10021 USA
[5] Univ Paris Sud, UMR Inserm 788, Le Kremlin Bicetre, France
关键词
Experimental autoimmune encephalomyelitis; Nestorone; Microglia; Behavior; ADULT HIPPOCAMPAL NEUROGENESIS; MULTIPLE-SCLEROSIS; INFLAMMATION ALTERS; CELL-PROLIFERATION; DENTATE GYRUS; BRAIN-INJURY; SPINAL-CORD; MOUSE MODEL; MALE-MICE; NEUROPROTECTION;
D O I
10.1016/j.jneuroim.2014.08.619
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Progesterone plays a protective role in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). Besides spinal cord neuropathology, MS patients present a dysfunctional hippocampus. In this work we studied the therapeutic effects of the progestin Nestorone in the brain of mice with chronic EAE. Nestorone decreased clinical grade and enhanced motor behavior. In addition, it increased cell proliferation and doublecortin positive neuroblasts in the hippocampus, increased GABAergic interneurons and attenuated the number of Iba1 + microglia/macrophages, events possibly linked to enhancement of neurogenesis. Therefore, Nestorone protected against hippocampus abnormalities and improved functional outcomes of EAE mice, suggesting its potential value for MS. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [1] Neuroprotective Effects of Progesterone in Chronic Experimental Autoimmune Encephalomyelitis
    Giatti, S.
    Caruso, D.
    Boraso, M.
    Abbiati, F.
    Ballarini, E.
    Calabrese, D.
    Pesaresi, M.
    Rigolio, R.
    Santos-Galindo, M.
    Viviani, B.
    Cavaletti, G.
    Garcia-Segura, L. M.
    Melcangi, R. C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2012, 24 (06) : 851 - 861
  • [2] Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands
    Elloso, MM
    Phiel, K
    Henderson, RA
    Harris, HA
    Adelman, SJ
    JOURNAL OF ENDOCRINOLOGY, 2005, 185 (02) : 243 - 252
  • [3] Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist
    Lou, Zhi-Yin
    Zhao, Chong-Bo
    Xiao, Bao-Guo
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (01) : 84 - 95
  • [4] Efficacy of angiogenesis inhibitors in experimental autoimmune encephalomyelitis
    MacMillan, C. J.
    Doucette, C. D.
    Hoskin, D. W.
    Easton, A. S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 : 19 - 19
  • [5] INFLUENCE OF T-CELL RECEPTOR GENES ON CHRONIC EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    JANSSON, L
    OLSSON, T
    HOLMDAHL, R
    IMMUNOGENETICS, 1993, 37 (06) : 466 - 468
  • [6] Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis
    Polak, PE
    Kalinin, S
    Dello Russo, C
    Gavrilyuk, V
    Sharp, A
    Peters, JM
    Richardson, J
    Willson, TM
    Weinberg, G
    Feinstein, DL
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 168 (1-2) : 65 - 75
  • [7] Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis
    Chandraratna, Roshantha A. S.
    Noelle, Randolph J.
    Nowak, Elizabeth C.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (02): : 1016 - 1026
  • [8] Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis
    Kong, Weimin
    Li, Hongbo
    Adhikary, Sabina
    Tuma, Ronald
    Ganea, Doina
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [9] Characterization of a novel sphingosine-1-phosphate-1 receptor agonist with activity in experimental autoimmune encephalomyelitis
    Bousquet, Peter
    Nelson, Christine
    Kuzmin, Elina
    Stoffel, Robert
    Cusack, Kevin
    Tian, Yu
    Waegell, Wendy
    Goudreau, Regina
    Fix, Shannon
    Konopacki, Donald
    Gordon, Tom
    Hayes, Martin
    Grongsaard, Pintipa
    Zhang, Xiaolei
    Schaffter, Lisa
    Wallace, Grier
    McRae, Bradford
    MULTIPLE SCLEROSIS, 2008, 14 : S33 - S33
  • [10] Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
    Ho, Peggy P.
    Steinman, Lawrence
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) : 1600 - 1605